Edwards Lifesciences Corp

Ownership Transactions Reported by 23 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	1	+580	0.2%	$85.74	+$49.8K
Sells	11	-239K	99.8%	$76.26	-$18.2M
Net	-10	-238K	-99.5%		-$18.2M

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Michael A. Mussallem	Director	$343M	-$2.49M	-0.72%	May 2, 2024
Scott B. Ullem	CVP, Chief Financial Officer	$21M	-$4.88M	-18.8%	Mar 26, 2025
Jean-Luc M. Lemercier	CVP, EMEACLA and JAPAC	$17.1M	-$1.21M	-6.64%	Jul 7, 2024
Donald E. Bobo Jr	CVP,Strategy/Corp Development	$15.4M	-$5.19M	-25.1%	Apr 14, 2025
Larry L. Wood	Global President TAVR & Surg	$15.1M	-$1.65M	-9.83%	Feb 16, 2025
Huimin Wang	CVP, Japan & Intercontinental	$7.52M			Jul 8, 2022
Kieran Gallahue	Director	$6.38M			May 8, 2024
Nicholas J. Valeriani	Director	$6.27M			May 8, 2024
Steven R. Loranger	Director	$5.76M	-$439K	-7.08%	Feb 14, 2025
Catherine M. Szyman	CVP, Critical Care	$5.69M			Sep 3, 2024
Bernard J. Zovighian	CEO, Director	$5.08M	-$1.13M	-18.3%	Mar 10, 2025
Robert W.A. Sellers	SVP, Corporate Controller	$3.25M			May 11, 2024
Martha H. Marsh	Director	$2.41M			May 12, 2023
Heisz Leslie Stone	Director	$2.28M	-$435K	-16%	Feb 13, 2025
Daveen Chopra	Cvp, Tmtt	$2.02M	-$216K	-9.64%	Dec 6, 2024
Daniel J. Lippis	Cvp, Japac	$1.61M	-$475K	-22.7%	Apr 8, 2025
Ramona Sequeira	Director	$1.2M			May 8, 2024
Paul A. Laviolette	Director	$917K			May 8, 2024
Wayne Markowitz	GM & SVP, Surgical	$696K	-$42.7K	-5.79%	Dec 6, 2024
Annette Bruls	Cvp, Emeacla	$534K			Aug 19, 2024
Andrew M. Dahl	SVP, Corporate Controller	$343K			Feb 22, 2025
Leslie C. Davis	Director	$260K			May 8, 2024
David T. Feinberg	Director	$213K			Jul 10, 2024

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.